Tag: Consolidate

  • Biocon to Consolidate Biologics Division in $5.5 Billion Merger

    Biocon to Consolidate Biologics Division in $5.5 Billion Merger

    Biocon Ltd will combine Biocon Biologics Ltd as an entirely owned subsidiary in a deal valuing the unit at $5.5 billion, the corporate mentioned on Saturday. Biocon will purchase the remaining stake in Biocon Biologics from Serum Institute Life Sciences, Tata Capital Progress Fund II and Activ Pine LLP through a share swap of 70.28…